Cj. Knight et al., ALTERED PLATELET-FUNCTION DETECTED BY FLOW-CYTOMETRY - EFFECTS OF CORONARY-ARTERY DISEASE AND AGE, Arteriosclerosis, thrombosis, and vascular biology, 17(10), 1997, pp. 2044-2053
Platelet activation state and responsiveness to physiological agonists
were measured in 65 patients with documented coronary artery disease
(54 male and 11 female; mean age, 58 years). Twelve patients (mean age
, 52 years), selected at random from the male cohort, were compared wi
th 12 age-matched male control subjects (mean age, 52 years) and with
10 normal, young male subjects (mean age, 25 years). Whole-blood flow
cytometry was used to measure platelet activation status exvivo and pl
atelet responsiveness to physiological agonists in vitro. Peripheral b
lood samples were analyzed for bound fibrinogen and expression of P-se
lectin, GPIb, and GPIIb-IIIa at rest and in response to ADP (0.1 to 10
mu mol/L) and thrombin (0.02 to 0.32 mu/mL). No significant differenc
es were seen in the basal levels of fibrinogen binding between any of
the groups, but P-selectin expression was significantly lower in patie
nts compared with age-matched control subjects (P=.0005). When stimula
ted with agonists, patients' platelets had significantly decreased fib
rinogen binding (P<.03) but no difference in P-selectin expression com
pared with the age-matched group. Both agonist-induced fibrinogen bind
ing and P-selectin expression were, however, higher in the young subje
cts compared with either the older control group or the patients (P<.0
5). GPIb and GPIIb-IIIa expression were lowest in the patients with an
gina and highest in the young control subjects, with levels in the age
-matched control subjects falling between these values. Data from the
total patient cohort (n=65) were identical to those in the smaller coh
ort (n=12). In conclusion, atherosclerosis impairs platelet aggregatel
y responses (fibrinogen binding) over and above the decreased response
seen with age. Platelet degranulation (P-selectin expression) is also
impaired in patients with coronary artery disease, but only in compar
ison with younger subjects, not age-matched controls.